about
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and int...
Read More
0.77
0.01
(1.32%)
300.3K
XNAS Volume
XNAS 14 May, 2026 4:19 PM (EDT)
Board Meeting
The next board meeting for Scynexis Inc is on 15 May 2026 for the purpose of SCYNEXIS Inc First Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Neutral
Scynexis Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..